1. |
骆美秀, 潘志, 王颖航. 氧化应激在类风湿关节炎中的调控机制及中药干预研究进展. 重庆医科大学学报, 2024, 49(10): 1055-1060.
|
2. |
Luo L, Hee JY, Zang S, et al. Natural environmental factors at birth on risk for rheumatoid arthritis: the impact of season, temperature, latitude, and sunlight exposure. BMC Public Health, 2025, 25(1): 1267. doi: 10.1186/s12889-025-22448-2.
|
3. |
Tsaltskan V, Firestein GS. Targeting fibroblast-like synoviocytes in rheumatoid arthritis. Curr Opin Pharmacol, 2022, 67: 102304. doi: 10.1016/j.coph.2022.102304.
|
4. |
Wu Z, Ma D, Yang H, et al. Fibroblast-like synoviocytes in rheumatoid arthritis: Surface markers and phenotypes. Int Immunopharmacol, 2021, 93: 107392. doi: 10.1016/j.intimp.2021.107392.
|
5. |
Du H, Zhang X, Zeng Y, et al. A Novel phytochemical, DIM, inhibits proliferation, migration, invasion and TNF-α induced inflammatory cytokine production of synovial fibroblasts from rheumatoid arthritis patients by targeting MAPK and AKT/mTOR signal pathway. Front Immunol, 2019, 10: 1620. doi: 10.3389/fimmu.2019.01620.
|
6. |
Sendo S, Machado CRL, Boyle DL, et al. Dysregulated NUB1 and neddylation enhances rheumatoid arthritis fibroblast-like synoviocyte inflammatory responses. Arthritis Rheumatol, 2024, 76(8): 1252-1262.
|
7. |
Tanaka Y, Westhovens R, Sun H, et al. Filgotinib radiographic and clinical efficacy versus other jak inhibitors and adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: A systematic review and network meta-analysis. Rheumatol Ther, 2025, 12(3): 453-468.
|
8. |
Burmester GR, Pope JE. Novel treatment strategies in rheumatoid arthritis. Lancet, 2017, 389(10086): 2338-2348.
|
9. |
Aletaha D. Precision medicine and management of rheumatoid arthritis. J Autoimmun, 2020, 110: 102405. doi: 10.1016/j.jaut.2020.102405.
|
10. |
陈钱, 陈长军, 候爽, 等. 黄酮类化合物体外诱导肿瘤细胞凋亡及其机制研究进展. 吉林医药学院学报, 2016, 37(3): 228-232.
|
11. |
Zheng Q, Wang D, Lin R, et al. Quercetin is a potential therapy for rheumatoid arthritis via targeting caspase-8 through ferroptosis and pyroptosis. J Inflamm Res, 2023, 16: 5729-5754.
|
12. |
Tang M, Zeng Y, Peng W, et al. Pharmacological aspects of natural quercetin in rheumatoid arthritis. Drug Des Devel Ther, 2022, 16: 2043-2053.
|
13. |
Fukuhara K, Ishikawa K, Yasuda S, et al. Intracerebroventricular 4-methylcatechol (4MC) ameliorates chronic pain associated with depression-like behavior via induction of brain-derived neurotrophic factor (BDNF). Cell Mol Neurobiol, 2012, 32(6): 971-977.
|
14. |
Hrubša M, Konečný L, Paclíková M, et al. The antiplatelet effect of 4-methylcatechol in a real population sample and determination of the mechanism of action. Nutrients, 2022, 14(22): 4798. doi: 10.3390/nu14224798.
|
15. |
吴洁, 杨学华, 马玲, 等. miR-26a-5p通过JAK2/STAT3信号通路对人类风湿关节炎成纤维样滑膜细胞凋亡的影响. 吉林大学学报 (医学版), 2021, 47(2): 460-468.
|
16. |
Chen C, Wang B, Zhao X, et al. Lithium promotes osteogenesis via Rab11a-facilitated exosomal Wnt10a secretion and β-catenin signaling activation. ACS Appl Mater Interfaces, 2024, 16(24): 30793-30809.
|
17. |
Chen C, Fu L, Luo Y, et al. Engineered exosome-functionalized extracellular matrix-mimicking hydrogel for promoting bone repair in glucocorticoid-induced osteonecrosis of the femoral head. ACS Appl Mater Interfaces, 2023, 15(24): 28891-28906.
|
18. |
Ge G, Bai J, Wang Q, et al. Punicalagin ameliorates collagen-induced arthritis by downregulating M1 macrophage and pyroptosis via NF-κB signaling pathway. Sci China Life Sci, 2022, 65(3): 588-603.
|
19. |
Zhendong Y, Changjun C, Haocheng H, et al. Regulation of macrophage polarization and pyroptosis by 4-methylcatechol alleviates collagen-induced arthritis via Nrf2/HO-1 and NF-κB/NLRP3 signaling pathways. Int Immunopharmacol, 2025, 146: 113855. doi: 10.1016/j.intimp.2024.113855.
|
20. |
王磊, 张益, 彭海宁, 等. 电纺明胶聚己内酯纳米纤维气凝胶结合软骨细胞外基质修复兔软骨损伤. 中华创伤杂志, 2021, 37(5): 449-456.
|
21. |
Thyberg I, Husberg M, Kastbom A. Physical and mental disability is evident 8 years after diagnosis in early rheumatoid arthritis despite contemporary medication and non-pharmacological interventions. Clin Rheumatol, 2025. doi: 10.1007/s10067-025-07399-8.
|
22. |
Torres A, Kang S, Mahony CB, et al. Role of mitochondria-bound HK2 in rheumatoid arthritis fibroblast-like synoviocytes. Front Immunol, 2023, 14: 1103231. doi: 10.3389/fimmu.2023.1103231.
|
23. |
Chen S, Xue W, Wu Z, et al. Quercetin, a compound of the total flavonoids of periploca forrestii schltr. , ameliorates rheumatoid arthritis by targeting TNF-α. J Inflamm Res, 2025, 18: 2879-2898.
|
24. |
Su J, Fan X, Zou Y, et al. Inhibition of aberrant activated fibroblast-like synoviocytes in rheumatoid arthritis by leishmania peptide via the regulation of fatty acid synthesis metabolism. Adv Sci (Weinh), 2025. doi: 10.1002/advs.202409154.
|
25. |
Jiang H, Lu Q, Huang X, et al. Sinomenine-glycyrrhizic acid self-assembly enhanced the anti-inflammatory effect of sinomenine in the treatment of rheumatoid arthritis. J Control Release, 2025, 382: 113718. doi: 10.1016/j.jconrel.2025.113718.
|
26. |
Liu X, Tao T, Yao H, et al. Mechanism of action of quercetin in rheumatoid arthritis models: meta-analysis and systematic review of animal studies. Inflammopharmacology, 2023, 31(4): 1629-1645.
|
27. |
Meng Q, Song C, Ma J, et al. Quercetin prevents hyperuricemia associated with gouty arthritis by inactivating the NLRP3/NF-κB signaling pathway. Chem Biol Drug Des, 2025, 105(4): e70103. doi: 10.1111/cbdd.70103.
|
28. |
周明, 汪家文, 路艳林, 等. SDF-1/CXCR4轴通过NF-κb信号通路调控炎症反应减轻动脉粥样硬化的形成. 重庆医科大学学报, 2025, 50(2): 237-243.
|
29. |
Tse AK, Wan CK, Shen XL, et al. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation. Biochem Pharmacol, 2005, 70(10): 1443-1457.
|
30. |
Kubo S, Nakayamada S, Tanaka Y. JAK inhibitors for rheumatoid arthritis. Expert Opin Investig Drugs, 2023, 32(4): 333-344.
|
31. |
Szekanecz Z, Buch MH, Charles-Schoeman C, et al. Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician. Nat Rev Rheumatol, 2024, 20(2): 101-115.
|
32. |
Zhou Y, Li P, Zhi Z, et al. Vanillic acid ameliorates collagen-induced arthritis by suppressing the inflammation response via inhibition of the MAPK and NF-κB signaling pathways. Inflammopharmacology, 2025, 33(4): 1949-1963.
|
33. |
Weyand CM, Goronzy JJ. The immunology of rheumatoid arthritis. Nat Immunol, 2021, 22(1): 10-18.
|